The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.
I strongly recommend this beautiful review on mantle cell lymphoma published in the @NEJM Amazing advances in this disease over the last 10 years. @TheIACH
Register for the IACH webinar on Managing toxicities in relapsed/refractory multiple myeloma: expert-led case discussions Thursday July 7, 2022 6:00pm (Paris), 5:00pm (London), 12:00pm (New York), 9:00am (Los Angeles) FREE Registration: https://us06web.zoom.us/webinar/register/WN_E7T9zIOpTRCqfcihDDCvmg @Mohty_EBMT
#iwCART22 | Leading experts John Gribben, Mazyar Shadman, and Saar Gill discuss some of the barriers to CAR-T therapy in CLL & debate the optimal use of CAR-T in CLL:
The 27th Congress of the European Hematology Association (EHA) 2022, held in Vienna, Austria, and virtually, from 9 - 12 June 2022, saw leading experts from around the world gather to discuss the most exciting updates in the field of hematology. Key updates on CAR-T therapy, transplant research, novel drugs, and more were showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, thalassemia, and beyond.
I strongly recommend this beautiful review on mantle cell lymphoma published in the @NEJM Amazing advances in this disease over the last 10 years. @TheIACH
Register for the IACH webinar on Managing toxicities in relapsed/refractory multiple myeloma: expert-led case discussions Thursday July 7, 2022 6:00pm (Paris), 5:00pm (London), 12:00pm (New York), 9:00am (Los Angeles) FREE Registration: https://us06web.zoom.us/webinar/register/WN_E7T9zIOpTRCqfcihDDCvmg @Mohty_EBMT
#iwCART22 | Leading experts John Gribben, Mazyar Shadman, and Saar Gill discuss some of the barriers to CAR-T therapy in CLL & debate the optimal use of CAR-T in CLL:
Watch the EHA 2022 MPN Session with leading experts Ruben Mesa, Claire Harrison, and Jean-Jacques Kiladjian as they discuss the most exciting updates from the meeting.